CC-90001

DB18445InvestigationalSmall molecule

CC-90001: Overview.

Chemical structure of CC-90001
Mechanism
Curator reviewed
Formula / weight
C16H27N5O2 · 321.425 g/mol (avg)
Also known as
2-((1,1-DIMETHYLETHYL)AMINO)-4-(((1R,3R,4R)-3-HYDROXY-4-METHYLCYCLOHEXYL)AMINO)-5-PYRIMIDINECARBOXAMIDE · 2-(TERT-BUTYLAMINO)-4-((1R,3R,4R)-3-HYDROXY-4-METHYLCYCLOHEXYLAMINO)-PYRIMIDINE-5-CARBOXAMIDE · 5-PYRIMIDINECARBOXAMIDE, 2-((1,1-DIMETHYLETHYL)AMINO)-4-(((1R,3R,4R)-3-HYDROXY-4-METHYLCYCLOHEXYL)AMINO)-
Code names
CC-90001

Resolves to

Compound
UNIIJD5ZWE631KCAS1403859-14-2ChEMBLCHEMBL4847106
Structure
InChIKeyQBBRJRLJWXRSHQ-CKYFFXLPSA-NSMILESC[C@@H]1CC[C@H](C[C@H]1O)NC1=NC(NC(C)(C)C)=NC=C1C(N)=O
Transporters
Q9Y6L6SLCO1B1P08183ABCB1Q9UNQ0ABCG2Q8TCC7SLC22A8O15244SLC22A2Q96FL8SLC47A1Q9NPD5SLCO1B3Q86VL8SLC47A2

What you can answer from here — as of July 09, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
8TransportersSubstrate / inhibitor direction, not just membership
Listed above
9Clinical trialsPhase, status and sponsor resolved per trial
Sign in
15+ReferencesStructured and connected to the statements they support
Sign in

Which companies are running trials of CC-90001, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In